|
|
||||||||
Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut
Submitted 12 July 2005 ; accepted in final form 26 September 2005
| ABSTRACT |
|---|
|
|
|---|
kidney; out-of-equilibrium solutions; acid-base; volume reabsorption
80% of the filtered HCO3 as follows. The PT cell actively secretes H+ into the tubule lumen (1, 6, 35) and uses this H+ to titrate filtered HCO3 in the lumen to CO2 and H2O, catalyzed by apical carbonic anhydrase IV (9, 36, 37). The newly formed CO2 and H2O then diffuse into the PT cells, where carbonic anhydrase II (36, 37) catalyzes the regeneration of H+ and HCO3. The cell extrudes the H+ across the apical membrane via Na-H exchangers (4, 5, 30) and H+ pumps (20), while exporting the HCO3 across the basolateral membrane, mainly via the electrogenic Na/HCO3 cotransporter (7, 15, 32, 33). Using out-of-equilibrium (OOE) CO2/HCO3 solutions to alter [CO2], [HCO3], or [H+] one at a time (40, 41, 43), our laboratory demonstrated that, at least in regard to acute acid-base disturbances, H+ secretion by the PT responds not to changes in pH, but only to changes in basolateral [CO2] and [HCO3] (43). Thus, in the case of acute respiratory acidosis, the PT cell senses the increase in blood [CO2] per se, which is a powerful stimulus for HCO3 reabsorption.
Perhaps the most powerful hormonal stimulus for HCO3 reabsorption is ANG II. The first report of the effects of ANG II on PT transport was in 1968 by Burg and Orloff (12) on isolated, perfused rabbit PTs. They noted that adding
2 x 106 M ANG II to the basolateral solution had no detectable effect on the rate of fluid absorption (JV). In a 1974 rat micropuncture study, Steven (38) reported that
2 x 105 M basolateral ANG II lowered JV, whereas 1 x 107 M had no effect. Harris and Young (23) later showed that basolateral ANG II has a biphasic effect on Na+ reabsorption in the rat PT, stimulating at low doses (1012-1010 M) and inhibiting at higher doses (3 x 107-3 x 106 M). Shuster and colleagues (34) in 1984 demonstrated a similar biphasic effect of basolateral ANG II on JV in isolated, perfused rabbit PTs, ruling out a role of sympathetic innervation on the JV response. In 1991, working in isolated, perfused rat proximal straight tubules (PSTs), Garvin (19) found that 1010 M basolateral ANG II increases both JHCO3 and JV. At about the same time, Chatsudthipong and Chan (14) found that high levels of basolateral ANG II reduce JHCO3 in rats and that these effects are blocked by saralasin, an antagonist of ANG II receptors.
As far as the effects of luminal ANG II are concerned, in a 1988 micropuncture study, Liu and Cogan (26) showed that low-dose luminal ANG II (1012-1011 M) increases HCO3 reabsorption (JHCO3) even in a denervated rat kidney. The 1990 study on the rat PT by Wang and Chan (39) extended the earlier observations by showing that increasing levels of luminal ANG II have biphasic effects on JHCO3 as well as JV. Consistent with these last two papers, Morduchowicz et al. (29), working in brush-border membrane vesicles, showed that ANG II stimulates Na-H exchange. Li et al. (25) in 1994 and Du et al. (17) in 2003 extended the biphasic effects of ANG II on JV to the lumen of the isolated, perfused rabbit PT. In 1997, working in isolated perfused rabbit proximal convoluted tubule (PCTs), Baum et al. (2) found that, in the presence but not in the absence of a luminal ACE inhibitor, low-dose luminal ANG II increased both JV and JHCO3.
The pattern that emerges from the above work is that, whether applied to the luminal or basolateral surface of the PT, low-dose ANG II generally increases JV and JHCO3, whereas high-dose ANG II generally has the opposite effect. In fact, until our observation that basolateral CO2 is also a powerful stimulus for HCO3 reabsorption (43), low-dose ANG II was the single most powerful known stimulus. The purposes of the present study were to determine whether 1) the effects of basolateral CO2 and low-dose ANG II, added to either the bath (i.e., basolateral solution) or lumen (i.e., luminal solution), are additive and 2) high-dose ANG II antagonizes the stimulatory effects of CO2.
Our approach was to use OOE solutions to vary basolateral [CO2] from 0 to 20% while keeping basolateral [HCO3] and pH fixed near their physiological values in isolated, perfused rabbit S2 PTs. We found that low-dose (i.e., 1011 M) ANG II, whether added to the bath or lumen, maximally increased JHCO3 at low basolateral (BL) [CO2], but that the effects tended to wane at high values of [CO2]BL. High-dose ANG II (i.e., 109 M) added to the bath produced a uniform decrease in JHCO3, regardless of [CO2]BL. When added to the lumen, high-dose ANG II had no effect when [CO2]BL was 0%, but increasingly larger inhibitor effects at high values of [CO2]BL.
| METHODS |
|---|
|
|
|---|
20 mg) of intravenous pentobarbital sodium. An incision of the abdominal wall exposed the left kidney, which we rapidly removed and then cut into coronal slices that we kept in cold (4°C) modified Hanks' solution (solution 1 in Table 1). Microdissection of the slice was carried out by hand in the same solution under a dissection microscope, using fine forceps, to yield individual midcortical S2 segments 1.51.7 mm in length, as detailed in Ref. 41. We cannulated the perfusion end of the tubule using concentric holding, perfusion and exchange pipettes. We cannulated the collection end of the tubule using a holding pipette and collected samples using a calibrated collection pipette (volume
55 nl), as summarized in Fig. 1B of Ref. 41. The mean length of perfused tubules in our JHCO3/JV experiments, as measured with an eyepiece micrometer, was 1.22 ± 0.01 mm (n = 99 tubules), representing the distal end of the PCT. The mean luminal collection rate was 12.3 ± 0.1 nl/min (n = 198 collection periods). We perfused the basolateral side of the tubule (i.e., "bath") at 7 ml/min, with a solution at 37°C.
|
|
7146, catalogue no. NET-086L, PerkinElmer Life Sciences, Boston, MA) as the volume marker. Solution 3, which contained 2% albumin, flowed through the bath during a 20- to 30-min warm-up period at 37°C. Following the warm-up period, all experiments had two periods for the collection of luminal fluid. During the first of these, the bath contained solution 4, with or without ANG II. During the second collection period, the bath contained ANG II dissolved in solutions 4, 5, 6, 7, or 8. In experiments in which we perfused the lumen with ANG II, the hormone was present in the lumen throughout the experiment; however, in these experiments, ANG II was always absent from the bath during both collection periods. We generated OOE CO2/HCO3 solutions (solutions 5-8) by rapidly mixing streams of two dissimilar solutions (40) and delivering the newly mixed solution to the tubule within
200 ms. All solutions had osmolalities of 300 ± 2 mosmol/kgH2O. Measurement of JHCO3 and JV. In each of the two collection periods, we allowed the tubule to stabilize in the appropriate bath solution for 58 min, removed and discarded the fluid that had accumulated in the holding pipette at the collection end of the tubule, and then began a series of three timed and calibrated collections. The first two were subsequently analyzed for [3H]methoxyinulin for use in the calculation of JV, and the third was analyzed for total CO2 for use in the calculation of JHCO3. Our measurement of JHCO3 (pmol·min1·mm1 tubule length) and JV (nl·min1·mm1) was similar to that used by McKinney and Burg (28) and identical to our previous approach (41, 43). We determined total CO2 in aliquots of the perfusate and collected fluid using a WPI "NanoFlo" device (World Precision Instruments, Sarasota, FL) together with Diagnostic Kit 132-A (Sigma, St. Louis, MO). In this paper, the values that we report for JHCO3 (or JV) in first collection period are unnormalized mean values. The values that we report for JHCO3 (or JV) in the second collection period are normalized, mean values computed as described previously (43). Briefly, in each experiment, we divided the JHCO3 (or JV) value obtained during the second collection period by the comparable values obtained during the first collection period; the result was a pair of second/first collection-period ratios. We then multiplied 1) the second/first ratio for JHCO3 (or JV) in a particular experiment by 2) the unnormalized, mean, JHCO3 (or JV) value that we obtained during the first collection periods in a series of experiments following the identical protocol.
Data analysis. For comparisons at 0, 5, and 20% basolateral CO2, we performed one-way ANOVA and Dunnett's multiple comparison for ANOVA for five means using KaleidaGraph (Version 4, Synergy Software, Reading, PA). In this analysis, which we applied separately for JHCO3 and JV at each level of [CO2]BL, we compared the control condition (no hormone) with basolateral 1011 M ANG II, basolateral 109 M ANG II, luminal 1011 M ANG II, and luminal 109 M ANG II. For comparisons at 2.5 and 10% basolateral CO2, we performed two-tailed, unpaired t-tests using the Analysis Toolpack of Microsoft Excel. Results are given as means ± SE, with the number of tubules (n) from which it was calculated.
| RESULTS |
|---|
|
|
|---|
|
Figure 1B summarizes the JV data, which we analyzed using the same ANOVA approach summarized in the previous paragraph. The overall P value was 0.00013. The effect of 1011 M basolateral ANG II on JV was stimulatory, as it was for JHCO3. The low dose of the peptide increased the mean JV from 0.46 ± 0.03 to 0.62 ± 0.05 nl·min1·mm1 (P = 0.0087). On the other hand, adding 109 M basolateral ANG II did not have a statistically significant effect on JV, which changed from 0.46 ± 0.03 under control conditions to 0.41 ± 0.05 nl·min1·mm1 in the presence of the high dose of the peptide (P = 0.8033).
Our control JV value of 0.46 nl·min1·mm1 is about two-thirds as great as the value reported by Schuster et al. (34), who worked with a combination of S1 and S2 segments from midcortical and juxtamedullary nephrons. On the other hand, our observed 36% increase of JV with 1011 M ANG II is about twice as great as that observed by the earlier investigators. Our JV data confirm the earlier observations of others, made in a combination of rat (14, 23, 38) and rabbit (34) PTs, that increasing levels of basolateral ANG II have a biphasic effect on JV. In addition, we observed that increasing levels of basolateral ANG II have a biphasic effect on JHCO3. Our JHCO3 data are consistent with those made by Garvin (19) in rat PSTs for low-dose ANG II, and with those made in rats by Chatsudthipong and Chan (14) for high-dose ANG II.
Effects of basolateral ANG II on the basolateral CO2 dependence of JHCO3 and JV. A previous study from our laboratory demonstrated that increasing [CO2]BL from 0 to 20%, using OOE technology to fix [HCO3]BL at 22 mM and fix pHBL at 7.4, substantially stimulated bicarbonate reabsorption by the rabbit S2 PT (43). In the present study, we examined the effects of low- or high-dose basolateral ANG II on the basolateral CO2 dependence of JHCO3. In this series of experiments, the bath contained 1011 or 109 M ANG II plus an equilibrated 5% CO2/22 mM HCO3/pH 7.40 solution during the first collection period, and an OOE solution containing the same level of ANG II and the same 22 mM HCO3/pH 7.40 but a variable level of CO2 during the second collection period.
Effect of low-dose ANG II. The diamonds in Fig. 2A summarize JHCO3 data obtained in the presence of 1011 M basolateral ANG II as we increased [CO2]BL from 0% CO2 (solution 5) to 20% CO2 (solution 8) at a fixed [HCO3]BL of 22 mM and a fixed pHBL of 7.4. The circles summarize comparable control data in the absence of added ANG II. These control data are from an earlier study (43), augmented by 12 additional experiments at 5% CO2 from Fig. 1A. In the previous section, we discussed the use of one-way ANOVA for five groups to analyze the data at a [CO2]BL of 5%. We similarly used one-way ANOVA for five groups (Figs. 2A and 4A) to analyze the data at [CO2]BL values of 0 and 20%. The overall P values were <0.0001 for both the 0 and 20% data. In addition, we used a t-test to analyze the data at [CO2]BL values of 2.5 and 10% in Fig. 2A. Compared with the control condition, 1011 M basolateral ANG II produced a statistically significant increase in JHCO3 at 0 (P = 0.041) and 5% CO2 (P < 0.0001). The difference was not statistically significant at either 2.5 (P = 0.092) or 10% CO2 (P = 0.51). Basolateral 1011 M ANG II produced a small but statistically significant decrease in JHCO3 at 20% CO2 (P = 0.032). Viewed differently, low-dose basolateral ANG II steepens relationship between JHCO3 and [CO2]BL at low levels of [CO2]BL (i.e., 05%), but eliminated the stimulation by CO2 at higher [CO2]BL levels.
|
|
Effect of high-dose ANG II. The squares in Fig. 2A summarize JHCO3 data obtained in the presence of 109 M basolateral ANG II as we increased [CO2]BL from 0% CO2 to 20% CO2 at a fixed [HCO3]BL of 22 mM and a fixed pHBL of 7.4. The statistical analysis of these JHCO3 data was part of the same JHCO3 ANOVA discussed two paragraphs above. Compared with the control condition, high-dose basolateral ANG II produced a statistically significant decrease in JHCO3 at all three levels of [CO2]BL: 0% (P = 0.0049), 5% (P < 0.0001), and 20% (P < 0.0001). Viewed differently, high-dose basolateral ANG II flattens the relationship between JHCO3 and [CO2]BL at low levels of [CO2]BL (i.e., 05%) and eliminates CO2 sensitivity at higher [CO2]BL levels.
The statistical analysis of the JV data was part of the same JV ANOVA discussed two paragraphs above. Compared with the control situation with no added hormone (circles in Fig. 2B), high-dose basolateral ANG II (squares) had no significant effect on JV (Fig. 2B).
Effects of luminal ANG II on JHCO3 and JV with equilibrated CO2/HCO3 solutions in the bath. In our next set of studies, all of the data came from the first collection period of experiments. The open bar in Fig. 3A repeats the control JHCO3 data from Fig. 1A. The gray bar in Fig. 3A represents the effect on JHCO3 of perfusing the lumen with 1011 M ANG II, and the filled bar represents the effect on JHCO3 of perfusing the lumen with 109 M ANG II. The statistical analysis of these JHCO3 data was part of the same JHCO3 ANOVA discussed in conjunction with Fig. 1A. Luminal 1011 M ANG II significantly increased JHCO3 from 56 ± 3 to 76 ± 7 pmol·min1·mm1 (P = 0.011). In contrast, adding a "high dose" of 109 M ANG II caused JHCO3 to change by a statistically insignificant amount, from 56 ± 3 to 46 ± 4 pmol·min1·mm1 (P = 0.34).
The stimulation by 1011 M ANG II that we observed confirms the observation by others in rat PTs by Wang and Chan (39). These same authors found that 108 M luminal ANG II reduced JHCO3 in rat, whereas we observed no significant effect at 109 M. In rabbit PCTs, Baum et al. (2) found no effect of luminal ANG II at concentrations from 1011 to 2 x 108 M. However, in the presence of luminal enalaprilat, these authors found that 1010 M luminal ANG II did indeed increase JHCO3. Two technical differences between our study and that of Baum et al. is that they perfused the bath at 0.5 ml/min (vs. 7.0 ml/min) and added 6 g/dl albumin to the bath throughout the experiment (vs. 2 g/dl only during the warm-up period).
The statistical analysis of the JV data in Fig. 3B was part of the same JV ANOVA discussed in conjunction with Fig. 1B. Luminal 1011 M ANG II changed the mean JV by a statistically insignificant amount from 0.46 ± 0.03 to 0.60 ± 0.06 nl·min1·mm1 (P = 0.14). Others had observed a stimulation by low-dose ANG II on rabbit PTs (17, 25). We found that adding 109 M luminal ANG II significantly increased JV from 0.46 ± 0.03 to 0.67 ± 0.06 nl·min1·mm1 (P = 0.014), which is in a direction opposite that seen by others in the rabbit (17, 25) or rat (39).
Effects of luminal ANG II on the basolateral CO2 dependence of JHCO3 and JV. In this series of studies, the lumen contained 1011 or 109 M ANG II throughout the experiment. During the first collection period, the bath contained equilibrated 5% CO2/22 mM HCO3/pH 7.40, while during the second collection period the bath contained an OOE solution with the same 22 mM HCO3/pH 7.40 but a variable level of CO2.
Effect of low-dose ANG II. The diamonds in Fig. 4A summarize JHCO3 data obtained in the presence of 1011 M luminal ANG II as we increased [CO2]BL from 0% CO2 (solution 5) to 20% CO2 (solution 8) at a fixed [HCO3]BL of 22 mM and a fixed pHBL of 7.4. The diamond at 5% CO2 represents the same data that we already presented in Fig. 3A (see bar labeled the 1011 M). The circles summarize the control data in the absence of added ANG II. These control data are the same as those presented in Fig. 2A. The statistical analysis of these JHCO3 data was part of the same JHCO3 ANOVA discussed in conjunction with Fig. 2A. Compared with the control condition, 1011 M luminal ANG II produced a statistically significant increase in JHCO3 at 0% (P = 0.0023) and 5% CO2 (P = 0.011). However, the difference was not statistically significant at a [CO2]BL of 20% (P = 0.055). Viewed differently, low-dose luminal ANG II produces a modest upward shift of the relationship between JHCO3 and [CO2]BL and low [CO2]BL values but eliminated the stimulation by 20% CO2.
The statistical analysis of the JV data was part of the same JV ANOVA discussed in conjunction with Fig. 2B. Compared with the control situation with no added hormone (circles in Fig. 4B), low-dose luminal ANG II (diamonds) produced a statistically significant increase in JV (diamonds) at 0% CO2 (P = 0.0020) but did not have a significant effect at 5 (P = 0.14) or 20% CO2 (P = 0.99).
Effect of high-dose ANG II. The squares in Fig. 4A summarize JHCO3 data obtained in the presence of 109 M luminal ANG II as we increased [CO2]BL from 0% CO2 to 20% CO2 at a fixed [HCO3]BL of 22 mM and a fixed pHBL of 7.4. The statistical analysis of these JHCO3 data was part of the same JHCO3 ANOVA discussed in conjunction with Fig. 2A and the diamonds in Fig. 4A. Compared with the control condition, high-dose luminal ANG II had no effect on JHCO3 at 0% CO2 (P = 1.00) or 5% (P = 0.34), but produced a statistically significant decrease at 20% CO2 (P < 0.0001). Viewed differently, high-dose basolateral ANG II flattened the relationship between JHCO3 and [CO2]BL.
The statistical analysis of these JV data was part of the same JV ANOVA discussed in conjunction with Fig. 2B and the diamonds in Fig. 4B. Compared with the control situation with no added hormone (circles in Fig. 4B), high-dose luminal ANG II (diamonds) produced a statistically significant increase in JV at 0% (P = 0.0075) and 5% CO2 (P = 0.014). The hormone did not have a statistically effect at 20% CO2 (P = 0.55).
| DISCUSSION |
|---|
|
|
|---|
High-dose ANG II (nM-µM range), like low-dose ANG II, appears to act via AT1A receptors: high-dose luminal ANG II fails to reduce JHCO3 in AT1A-deficient mice (42). Cumulative evidence suggests that, at least in part, high-dose ANG II acts via PLA2 to release arachidonic acid (AA). In the epoxygenase pathway, a cytochrome P-450 enzyme then converts this AA to a metabolite such as 5,6-EET (3, 21, 24).
Our data obtained with the equilibrated CO2/HCO3 solution, [CO2]BL = 5%, [HCO3]BL = 22 mM, and pHBL 7.4, generally confirm earlier observations that both basolateral and luminal ANG II have biphasic effects on JHCO3. We believe that ours is the first study to examine the effects of low- or high-dose basolateral ANG II on JHCO3 in a rabbit PT.
Mutual interdependence of the effects of basolateral ANG II and basolateral CO2 on JHCO3. As shown in Fig. 2A, 1011 M basolateral ANG II tends to stimulate HCO3 reabsorption at low values of [CO2]BL but actually produces a small inhibition at the highest [CO2]BL. The upper curve in Fig. 5A is a replot of these data and confirms the general trend that, as [CO2]BL rises, the fractional stimulation produced by low-dose ANG II tends to fall, eventually turning into a small inhibition. Returning to Fig. 2A, we recall that 109 M basolateral ANG II inhibits HCO3 reabsorption at all values of [CO2]BL. The lower curve in Fig. 5A, a replot of these data, suggests that, as [CO2]BL rises, the fractional inhibition produced by high-dose ANG II is at first stable and then tends to increase at the highest [CO2]BL. In other words, under conditions in which the JHCO3 response to the CO2-sensing mechanism is greatest, low-dose ANG II produces the least stimulation and high-dose ANG II produces the greatest inhibition.
|
|
In Fig. 6B, the black curve is a replot of the data at [CO2]BL = 5% in Fig. 4A. These results verify the biphasic effect of luminal ANG II under "control" basolateral acid-base conditions. The red curve in Fig. 6B, a replot of the data at [CO2]BL = 0% in Fig. 4A, shows that, with minimal stimulation of the basolateral CO2-sensing mechanism, luminal ANG II has a blunted biphasic effect on JHCO3. That is, low-dose ANG II increases JHCO3 but high-dose ANG II has no effect. This result contrasts to that with basolateral ANG II (see red curve in Fig. 6A), which produces a full biphasic effect (i.e., inhibition at high-dose ANG II) at [CO2]BL = 0%. The green curve in Fig. 6B, a replot of the data at [CO2]BL = 20% in Fig. 4A, shows that, with maximal stimulation of the basolateral CO2-sensing mechanism, luminal ANG II still has a biphasic effect on JHCO3. This result contrasts to that with basolateral ANG II (see green curve in Fig. 6A), which loses its biphasic effect at [CO2]BL = 20%.
In conclusion, the mutual effects of 1) basolateral or luminal ANG II on the basolateral CO2 dependence of JHCO3 and 2) basolateral [CO2] on the basolateral or luminal ANG II dependence of JHCO3 suggest to us that the signal-transduction pathways for basolateral CO2 intersect or perhaps even merge with the signal-transduction pathways for 1) low-dose basolateral ANG II, 2) high-dose basolateral ANG II, 3) low-dose luminal ANG II, and 4) high-dose luminal ANG II.
Our results raise two additional issues concerning low- vs. high-dose ANG II. Obviously, the distinction between a "low" stimulatory and a "high" inhibitory dose of ANG II is somewhat arbitrary and may differ according to the species studied and experimental preparation employed. In addition, our data demonstrate that the distinction between low and high also depends on whether one is examining JHCO3 or JV. For example, at a [CO2]BL of 20%, 109 M luminal ANG II lowered JHCO3 (Fig. 3A) but had no significant effect on JV (Fig. 3B). Thus increasing levels of [ANG II]L may produce decreases in JHCO3 earlier than they produce decreases in JV. Finally, our data indicate that the distinction between low and high depends on [CO2]BL. Thus, at a [CO2]BL of 20%, 1011 M basolateral ANG II actually inhibited HCO3 reabsorption (green curve in Fig. 6A).
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Zhou and W. F. Boron Role of endogenously secreted angiotensin II in the CO2-induced stimulation of HCO3 reabsorption by renal proximal tubules Am J Physiol Renal Physiol, January 1, 2008; 294(1): F245 - F252. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, P. Bouyer, and W. F. Boron Role of the AT1A receptor in the CO2-induced stimulation of HCO3- reabsorption by renal proximal tubules Am J Physiol Renal Physiol, July 1, 2007; 293(1): F110 - F120. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Boron Acid-Base Transport by the Renal Proximal Tubule J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2368 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, P. Bouyer, and W. F. Boron Role of a tyrosine kinase in the CO2-induced stimulation of HCO3- reabsorption by rabbit S2 proximal tubules Am J Physiol Renal Physiol, August 1, 2006; 291(2): F358 - F367. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |